{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:29Z","timestamp":1740108389350,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10096-021-04200-x","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:23:43Z","timestamp":1613838223000},"page":"1503-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteraemia\u00a0- A retrospective cohort study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-4464","authenticated-orcid":false,"given":"Khawaja M.","family":"Talha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rommel","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeha","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verda","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rizwan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Palraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,20]]},"reference":[{"issue":"6","key":"4200_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1469-0691.12144","volume":"19","author":"KB Laupland","year":"2013","unstructured":"Laupland KB (2013) Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 19(6):492\u2013500","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4200_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","volume":"204","author":"NE Holmes","year":"2011","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O\u2019Sullivan MV et al (2011) Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 204(3):340\u2013347","journal-title":"J Infect Dis"},{"issue":"11","key":"4200_CR3","doi-asserted-by":"publisher","first-page":"948. e1","DOI":"10.1016\/j.cmi.2016.07.034","volume":"22","author":"P Braquet","year":"2016","unstructured":"Braquet P, Alla F, Cornu C, Goehringer F, Piroth L, Chirouze C et al (2016) Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study. Clin Microbiol Infect 22(11):948. e1\u2013948. e7","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"4200_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajic.2015.08.005","volume":"44","author":"M Yasmin","year":"2016","unstructured":"Yasmin M, El Hage H, Obeid R, El Haddad H, Zaarour M, Khalil A (2016) Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York. Am J Infect Control 44(1):41\u201346","journal-title":"Am J Infect Control"},{"issue":"1","key":"4200_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/BPO.0b013e3181901c3a","volume":"29","author":"JJ Hawkshead III","year":"2009","unstructured":"Hawkshead JJ III, Patel NB, Steele RW, Heinrich SD (2009) Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop 29(1):85\u201390","journal-title":"J Pediatr Orthop"},{"issue":"5","key":"4200_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jmii.2015.08.015","volume":"50","author":"C-P Chen","year":"2017","unstructured":"Chen C-P, Liu M-F, Lin C-F, Lin S-P, Shi Z-Y (2017) The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections. J Microbiol Immunol Infect 50(5):619\u2013626","journal-title":"J Microbiol Immunol Infect"},{"key":"4200_CR7","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical, Institute LS","year":"2017","unstructured":"Clinical, Institute LS (2017) Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, PA"},{"issue":"2","key":"4200_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Mart\u00ednez JA, Pisos E, Almela M, Dimova VP et al (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46(2):193\u2013200","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4200_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/596629","volume":"199","author":"Y Maor","year":"2009","unstructured":"Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199(5):619\u2013624","journal-title":"J Infect Dis"},{"issue":"9","key":"4200_CR10","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1128\/AAC.00658-16","volume":"60","author":"SM Baxi","year":"2016","unstructured":"Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E et al (2016) Vancomycin MIC does not predict 90-day mortality, readmission, or recurrence in a prospective cohort of adults with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 60(9):5276\u20135284","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4200_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ijantimicag.2017.12.028","volume":"51","author":"K Bouiller","year":"2018","unstructured":"Bouiller K, Laborde C, Aho SL, Hocquet D, Pechinot A, Le Moing V et al (2018) No effect of vancomycin MIC\u2265 1.5 mg\/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia. Int J Antimicrob Agents 51(5):721\u2013726","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"4200_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"key":"4200_CR13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208","journal-title":"J Biomed Inform"},{"issue":"7","key":"4200_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME et al (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355(7):653\u2013665","journal-title":"N Engl J Med"},{"issue":"1","key":"4200_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00365540500372846","volume":"38","author":"R Khatib","year":"2006","unstructured":"Khatib R, Johnson LB, Fakih MG, Riederer K, Khosrovaneh A, Shamse Tabriz M et al (2006) Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand J Infect Dis 38(1):7\u201314","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"4200_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/cid\/ciz257","volume":"70","author":"E Minejima","year":"2020","unstructured":"Minejima E, Mai N, Bui N, Mert M, Mack WJ, She RC et al (2020) Defining the breakpoint duration of Staphylococcus aureus Bacteremia predictive of poor outcomes. Clin Infect Dis 70(4):566\u2013573","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4200_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1634\/theoncologist.2012-0029","volume":"17","author":"SN Mahajan","year":"2012","unstructured":"Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V et al (2012) Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 17(10):1329\u20131336","journal-title":"Oncologist"},{"issue":"1","key":"4200_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cid\/cir764","volume":"54","author":"CL Moore","year":"2011","unstructured":"Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ (2011) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 54(1):51\u201358","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4200_CR19","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/cid\/cit112","volume":"56","author":"KP Murray","year":"2013","unstructured":"Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P et al (2013) Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg\/L: a matched cohort study. Clin Infect Dis 56(11):1562\u20131569","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4200_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/cid\/cit118","volume":"56","author":"A Weston","year":"2013","unstructured":"Weston A, Boucher HW (2013) Editorial commentary: early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time? Clin Infect Dis 56(11):1570\u20131572","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4200_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54(6):755\u2013771","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4200_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ijantimicag.2012.07.023","volume":"40","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Tansarli GS, Vardakas KZ, Rafailidis PI, Karageorgopoulos DE, Falagas ME (2012) Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents 40(6):496\u2013509","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"4200_CR23","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","volume":"17","author":"JT Jacob","year":"2013","unstructured":"Jacob JT, DiazGranados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17(2):e93\u2013e100","journal-title":"Int J Infect Dis"},{"issue":"15","key":"4200_CR24","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME (2014) Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 312(15):1552\u20131564","journal-title":"JAMA."},{"key":"4200_CR25","doi-asserted-by":"crossref","unstructured":"Ishaq H, Tariq W, Talha KM, Palraj BRV, Sohail MR, Baddour LM et al (2021) Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis. Infection.","DOI":"10.1007\/s15010-020-01568-4"},{"issue":"1","key":"4200_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/AAC.01133-10","volume":"55","author":"SJ van Hal","year":"2011","unstructured":"van Hal SJ, Paterson DL (2011) Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother 55(1):405\u2013410","journal-title":"Antimicrob Agents Chemother"},{"key":"4200_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jgar.2018.03.007","volume":"14","author":"J Ruiz","year":"2018","unstructured":"Ruiz J, Ramirez P, Concha P, Salavert-Llet\u00ed M, Villarreal E, Gordon M et al (2018) Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia. J Glob Antimicrob Resist 14:141\u2013144","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"4200_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3904\/kjim.2016.351","volume":"34","author":"T Kim","year":"2019","unstructured":"Kim T, Chong YP, Park KH, Bang KM, Park SJ, Kim SH et al (2019) Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia. Korean J Intern Med 34(1):184\u2013194","journal-title":"Korean J Intern Med"},{"issue":"3","key":"4200_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2017.03.008","volume":"88","author":"DM Martirosov","year":"2017","unstructured":"Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Lodise TP (2017) Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest\u00ae MIC values of 1.5 mg\/L: a pilot study. Diagn Microbiol Infect Dis 88(3):259\u2013263","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"4200_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10096-016-2603-2","volume":"35","author":"MM Gallardo-Garc\u00eda","year":"2016","unstructured":"Gallardo-Garc\u00eda MM, S\u00e1nchez-Esp\u00edn G, Ivanova-Georgieva R, Ru\u00edz-Morales J, Rodr\u00edguez-Bail\u00f3n I, Vi\u00f1uela Gonz\u00e1lez V et al (2016) Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study. Eur J Clin Microbiol Infect Dis 35(5):821\u2013828","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"4200_CR31","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/jac\/dkx096","volume":"72","author":"R San-Juan","year":"2017","unstructured":"San-Juan R, Fern\u00e1ndez-Ruiz M, Gasch O, Camoez M, L\u00f3pez-Medrano F, Dom\u00ednguez M et al (2017) High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 72(7):2102\u20132109","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4200_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mjafi.2013.11.008","volume":"70","author":"CN Chaudhari","year":"2014","unstructured":"Chaudhari CN, Tandel K, Grover N, Bhatt P, Sahni AK, Sen S et al (2014) In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus. Med J Armed Forces India 70(3):215\u2013219","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"4200_CR33","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1128\/AAC.01485-12","volume":"57","author":"NE Holmes","year":"2013","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MVN et al (2013) Vancomycin AUC\/MIC ratio and 30-day mortality in patients with <span class=\"named-content genus-species\" id=\"named-content-1\">Staphylococcus aureus<\/span> Bacteremia. Antimicrob Agents Chemother 57(4):1654\u20131663","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4200_CR34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C et al (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77(11):835\u2013864","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"4200_CR35","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JCM.00494-10","volume":"48","author":"K Amsler","year":"2010","unstructured":"Amsler K, Santoro C, Foleno B, Bush K, Flamm R (2010) Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens. J Clin Microbiol 48(9):3353\u20133357","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4200_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/jac\/dkt340","volume":"69","author":"SY Chen","year":"2014","unstructured":"Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC et al (2014) Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 69(1):211\u2013218","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04200-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:06:59Z","timestamp":1623762419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04200-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04200-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2021,2,20]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Approval was obtained from Mayo Institutional Review Board (IRB\/IACUC number: 19-005199)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Larry M. Baddour, MD reports consultant payments from Boston Scientific, Botanix Pharmaceuticals, and Roivant Sciences and royalty payments (authorship duties) from UpToDate, Inc. M. Rizwan Sohail, MD reports receiving funds from TYRX Inc. and Medtronic for prior research unrelated to this study administered according to a sponsored research agreement between Mayo Clinic and study sponsor that prospectively defined the scope of the research effort and corresponding budget, and honoraria\/consulting fees from Medtronic Inc. and Aziyo Biologics, Inc. Research Grant: Medtronic (significant - $40 K), Honoraria: Medtronic (significant $20 K), and Aziyo Biologics (modest $5 K). The other authors report no financial support or conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}